about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
0.68
0.02
(3.03%)
1.8M
XNAS Volume
XNAS 13 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..